Cholamandalam Financial Holdings Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Future growth expectations for Cholamandalam Financial Holdings Limited and Chola MS General Insurance include: - Visible growth in non-crop business from Q3 FY '26 following the end of 1/n reporting base effect. - Participation in the upcoming 3-year crop insurance tender nationwide aiming to regain lost crop business, enhancing revenue and profitability. - Expected reduction in motor own damage (OD) loss ratios by 3-5% over the next two quarters due to corrective actions in sourcing and vehicle/geography mix. - Planned measured increase in equity proportion of investment portfolio from current ~7% to 10% in the medium term. - Conservative approach on the 2-wheeler motor book to protect future liabilities but acceptance of potential for better investment income. - Management confidence in operational efficiencies and improved combined ratios leading to better ROEs, targeting 16-18% (IRDA basis) with potential economic ROE closer to 19-20% post IFRS transition. - Overall optimism for improved numbers in subsequent quarters despite a challenging year so far.

- No specific mention of current or future capex or strategic capital investments was made in the provided transcript. - The focus discussed pertained mainly to operational aspects such as underwriting, provisioning, motor insurance pricing, and potential ROE improvements. - Management noted plans to participate in a new 3-year tender for crop insurance business to regain lost volumes and improve profitability. - There was no explicit discussion of any capital expenditure or strategic investments such as listing the general insurance company, with management stating such decisions would be taken later by the Board if at all. - Investment portfolio adjustments were mentioned, such as gradually increasing equity allocation in investments from ~7% toward 10%, but not a strategic capital investment or capex in the business sense. In summary, the call did not highlight any announced or planned capex or strategic investments at this time.

The document on page 10 (and the Q3 FY26 transcript) does not provide specific details on current or expected orderbook or pending orders for Cholamandalam Financial Holdings Limited or its subsidiaries. The discussion primarily revolves around: - Insurance business performance, provisioning, pricing, and ROE. - No mention or disclosure about orderbook or pending orders. - Focus on motor insurance, health, crop insurance tenders, and premium growth. - Crop insurance tender expected next year, which the company plans to participate in for a 3-year contract, potentially bringing back some business. - No quantification or specifics on outstanding or expected orderbook/pending orders. Hence, no current or expected orderbook or pending orders information is available in the provided transcript.